PainReform to Participate in the H.C. Wainwright 25th Annual Global Investment Conference in New York City
Provided By GlobeNewswire
Last update: Sep 5, 2023
TEL AVIV, Israel, Sept. 05, 2023 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that Ilan Hadar, Chief Executive Officer of PainReform will be attending the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13, 2023 at the Lotte New York Palace Hotel in New York City.
1.86
-0.08 (-4.12%)
Find more stocks in the Stock Screener
PRFX Latest News and Analysis
4 days ago - ChartmillGet insights into the top gainers and losers of Wednesday's after-hours session.Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
